Parallax Volatility Advisers
KRTX

Parallax Volatility Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Parallax Volatility Advisers’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-148
Closed -$46.8K – 2497
2023
Q4 		$46.8K Buy
+148
New +$28.8K ﹤0.01% 1936
2023
Q1 		– Sell
-35,222
Closed -$6.92M – 3301
2022
Q4 		$6.92M Buy
35,222
+32,199
+1,065% +$6.9M 0.01% 912
2022
Q3 		$680K Buy
+3,023
New +$612K ﹤0.01% 1881

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Parallax Volatility Advisers's KRTX Position: Q1 2024 in Review

Parallax Volatility Advisers sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 148 shares — an estimated $46.8K sold.

Parallax Volatility Advisers first reported a position in KRTX in Q3 2022 and held it in 3 quarters. The position peaked at $6.92M in Q4 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Parallax Volatility Advisers reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 148 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $46.8K.
  • Parallax Volatility Advisers first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Parallax Volatility Advisers's Karuna Therapeutics, Inc. Common Stock position peaked at $6.92M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Parallax Volatility Advisers's 13F filing for Q1 2024, filed 15 May 2024.